Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL20485063

CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.N#C[Mn](=O)(=O)[O-].N#C[Mn](=O)(=O)[O-].N#C[Mn](=O)(=O)[O-].N#C[Mn](=O)(=O)[O-].N#C[Mn](=O)(=O)[O-].N#C[Mn](=O)(=O)[O-]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.52
SLC22A2 O15244 1/20 0.46
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
DNM1 Q05193 6/20 0.39
LSS P48449 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL3796267 0.86 SLC22A1 (0.71) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL2215 0.84 SLC22A1 (0.67) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL6694805 0.81 SLC22A1 (0.63) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL6694801 0.81 SLC22A1 (0.63) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL6694808 0.81 SLC22A1 (0.63) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL757473 0.79 SLC22A1 (0.67) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrylammonium SCHEMBL15901982 0.77 TSHR (0.42) TSHR
Tetrabuthylammonium SCHEMBL15822811 0.76 SLC22A1 (0.71) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL2824668 0.76 SLC22A1 (0.55) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL1204718 0.75 SLC22A1 (0.92) SLC22A1SLC22A2ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840504-B2 High performance inorganic complexes for next-generation redox flow batteries CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2020-11-17 US disclosed
US-20180254478-A1 HIGH PERFORMANCE INORGANIC COMPLEXES FOR NEXT-GENERATION REDOX FLOW BATTERIES CALIFORNIA INSTITUTE OF TECHNOLOGY 2018-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10840504-B2 High performance inorganic complexes for next-generation redox flow batteries ACAD9, LETM1, NOX4 SLC22A1 1018/4885SLC22A2 1032/4885ALDH1A1 481/4885
US-20180254478-A1 HIGH PERFORMANCE INORGANIC COMPLEXES FOR NEXT-GENERATION REDOX FLOW BATTERIES ACAD9, LETM1, NOX4 SLC22A1 1018/4885SLC22A2 1032/4885ALDH1A1 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.